Immatics N.V.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol IMTX:xnas
Currency USD
NASDAQ (Small cap)
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.692835bn
Data Provided by 
/ 
/